SCHEMBL2314352

SCHEMBL2314352

CC(=O)/C=C/C1=CC(C)(C)COc2ccc(C(F)(F)F)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
LMNA P02545 2/20 0.36
TRPV1 Q8NER1 1/20 0.34
ALK Q9UM73 1/20 0.33
DAO P14920 1/20 0.33
MAOB P27338 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
USP2 O75604 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
IDO1 P14902 3/20 0.31
TDO2 P48775 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314361 1.00 CCNB2 (0.36) CCNB2CDK1CCNB1GSK3BCDK5
SCHEMBL3604486 0.88 RXRA (0.41) LMNATRPV1ALDH1A1KDM4EHSD17B10
SCHEMBL3604482 0.88 RXRA (0.41) LMNATRPV1ALDH1A1KDM4EHSD17B10
SCHEMBL2316992 0.85 ALDH1A1 (0.39) TRPV1MAOBALDH1A1KDM4EHPGD
SCHEMBL2316995 0.85 ALDH1A1 (0.39) TRPV1MAOBALDH1A1KDM4EHPGD
SCHEMBL2314163 0.84 TGM2 (0.39) MAOBALDH1A1HPGD
SCHEMBL2314166 0.84 TGM2 (0.39) MAOBALDH1A1HPGD
SCHEMBL2315349 0.83 MAPT (0.35) LMNATRPV1MAOBALDH1A1KDM4E
SCHEMBL2315354 0.83 MAPT (0.35) LMNATRPV1MAOBALDH1A1KDM4E
SCHEMBL1400276 0.83 DAO (0.36) LMNADAOIDO1TDO2NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed